We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| One Health Group PLC | AQSE:OHGR | Aquis Stock Exchange | Ordinary Share | GB00BNNT0595 | Ordinary shares |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 185.00 | 150.00 | 300.00 | 225.00 | 175.00 | 185.00 | 0.00 | 16:29:55 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2022 to May 2024
TIDMOHGR
RNS Number : 9187U
One Health Group PLC
31 March 2023
One Health Group PLC
PDMR Share Dealing
TR1 - Notification of Major Holdings
31 March 2023
One Health Group PLC ("One Health" or the "Company") announces that Shantanu Shahane, a director and person discharging managerial responsibilities in the Company, purchased 60,000 ordinary shares of 0.5 pence each in the capital of the Company ("Ordinary Shares") following the exercise of options granted under the One Health Group Share Option Plan ("Share Options").
Further details of the disclosure made to the Company by Shantanu Shahane are contained in Appendix 1.
Following the above dealing, Shantanu Shahane is, directly or indirectly, beneficially interested in 350,000 Ordinary Shares representing 3.33% of the issued share capital of the Company.
Appendix 2 contains a disclosure form relating to Shantanu Shahane who has notified One Health that he controls over 3% of the Total Voting Rights in the Company as a result of his acquisition of Ordinary Shares outlined above.
Following the exercise of the Share Options, Derek Bickerstaff, a director and Chair of One Health and who controls over 3% of the Total Voting Rights in the Company, has notified One Health that his percentage interest in Ordinary Shares has reduced to approximately 57.09% of the issued share capital of the Company. Derek Bickerstaff did not acquire Ordinary Shares as a result of the exercise of the Share Options. Further details are contained in the disclosure form in Appendix 3.
This announcement contains inside information for the purposes of Article 7 of EU Regulation
596/2014. Which is part of the United Kingdom domestic law pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)("UK MAR").
The directors of One Health accept responsibility for this announcement.
Enquiries
One Health Group plc Via Square 1 Consulting Oberon Capital (AQSE Corporate Adviser and Broker) Nick Lovering, Mike Seabrook 020 3179 5300 Square 1 Consulting David Bick 020 7929 5599
Appendix 1
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Hot Features
Premium
1. Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Shantanu Shahane
=== ========== =========================== =============================================
2. Reason for the notification
=== ================ ====================================================================
a) Position/status: Medical Director
=== ========================================== ========================================
b Initial notification/Amendment: Initial notification
=== ========================================== ========================================
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
======================================================================================
a) Name: One Health Group plc
=== ========== ======================== ==================================================
b) LEI: 984500DC689F5BAD8732
=== ========== ======================== ==================================================
4. Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
========================================================================================
a) Description of the financial Ordinary shares of GBP0.005 each
instrument, type of instrument: ISIN Code: GB00BNNT0595
Identification code:
b) Nature of the transaction: Purchase of share pursuant to the
exercise of options
================================ ==================================
c) Price(s) and Volume (s): Purchase price(s). 66.7p per share
Volume(s): 60,000
================================ ==================================
d) Aggregated Information: 60,000
Aggregated volume:
Price: GBP40,200
================================ ==================================
e) Date of the transaction: 30 March 2023
================================ ==================================
f) Place of the transaction Aquis (AQSE)
================================ ==================================
Appendix 2
Disclosure forms re major share holdings
TR-1: standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the ONE HEALTH GROUP PLC
underlying issuer of existing shares 131 Psalter Lane Sheffield S11 8UX
to which voting rights are attached LEI: 984500DC689F5BAD8732
(ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights X
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify) (iii) :
----
3. Details of person subject to the notification obligation (iv)
Name Shantanu Shahane
City and country of registered office
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name As above
--------------------------------------------
City and country of registered office
(if applicable)
--------------------------------------------
5. Date on which the threshold was 30(th) March 2023
crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified 30(th) March 2023
(DD/MM/YYYY):
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) held in issuer
of 8. A) (total of 8.B (8.A + 8.B)
1 + 8.B 2) (vii)
------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 3.33% 3.33% 350,000
------------------ --------------------- -------------- --------------------
Position of N/A N/A
previous notification
(if
applicable)
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
---------------------
GB00BNNT0595 60,000 290,000 0.57% 2.76%
--------------------- --------------------- -------------------- ----------------
SUBTOTAL 8.
A 350,000 3.33%
-------------------------------------------- --------------------------------------
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
(x) (xi) be acquired if
the instrument
is
exercised/converted.
----------- ------------------------- -------------------------- ----------------
SUBTOTAL 8. B
1
------------------------- -------------------------- ----------------
B 2: Financial Instruments with similar economic effect according to
DTR5.3.1R (1) (b)
Type of financial Expiration Exercise/ Physical Number of % of voting
instrument date (x) Conversion or cash voting rights rights
Period (xi) Settlement
(xii)
---------------- ---------------- ----------------- ----------------
SUBTOTAL
8.B.2
----------------- ----------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights x
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional
rows as necessary) (xiv)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
Shantanu Shahane 0.57% 0.57%
---------------------- --------------------- ------------------------
Shahane Consultancy
Ltd 2.76% 2.76%
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-----------------------------------------------
The number and % of voting rights
held
-----------------------------------------------
The date until which the voting rights
will be held
-----------------------------------------------
11. Additional information (xvi)
Place of completion Aquis (AQSE)
Date of completion 30(th) March 2023
------------------
Appendix 3
TR-1: standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the ONE HEALTH GROUP PLC
underlying issuer of existing shares 131 Psalter Lane Sheffield S11 8UX
to which voting rights are attached LEI: 984500DC689F5BAD8732
(ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights X
----
Other (please specify) (iii) :
----
3. Details of person subject to the notification obligation (iv)
Name Derek Richard Bickerstaff
City and country of registered office
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name As above
--------------------------------------------
City and country of registered office
(if applicable)
--------------------------------------------
5. Date on which the threshold was 30(th) March 2023
crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified 30(th) March 2023
(DD/MM/YYYY):
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) held in issuer
of 8. A) (total of 8.B (8.A + 8.B)
1 + 8.B 2) (vii)
------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 57.09% 57.09% 6,000,000
------------------ --------------------- -------------- --------------------
Position of
previous notification
(if
applicable) 59.8% 59.8%
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
---------------------
GB00BNNT0595 6,000,000 57.09%
--------------------- --------------------- -------------------- ----------------
SUBTOTAL 8.
A 6,000,000 57.09%
-------------------------------------------- --------------------------------------
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
(x) (xi) be acquired if
the instrument
is
exercised/converted.
----------- ------------------------- -------------------------- ----------------
SUBTOTAL 8. B
1
------------------------- -------------------------- ----------------
B 2: Financial Instruments with similar economic effect according to
DTR5.3.1R (1) (b)
Type of financial Expiration Exercise/ Physical Number of % of voting
instrument date (x) Conversion or cash voting rights rights
Period (xi) Settlement
(xii)
---------------- ---------------- ----------------- ----------------
SUBTOTAL
8.B.2
----------------- ----------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled x
by any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional
rows as necessary) (xiv)
Name (xv) % of voting rights % of voting rights Total of both if
if it equals or through financial it equals or is
is higher than the instruments if it higher than the
notifiable threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
-----------------------------------------------
The number and % of voting rights
held
-----------------------------------------------
The date until which the voting rights
will be held
-----------------------------------------------
11. Additional information (xvi)
Place of completion Aquis (AQSE)
Date of completion 30(th) March 2023
------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGRGDXBBXDGXB
(END) Dow Jones Newswires
March 31, 2023 03:20 ET (07:20 GMT)
1 Year One Health Chart |
1 Month One Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
![Logo of Plian [PCHAIN] (PIUSD).](/common/images/company/COIN_PIUSD.png){kind=small}
